{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:41:45Z","timestamp":1785451305455,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012495","name":"Spondylitis Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.joca.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T20:01:18Z","timestamp":1571256078000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Association of tramadol with risk of myocardial infarction among patients with osteoarthritis"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tomasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"LaRochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2019.10.001_bib1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2019.10.001_bib2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/art.39704","article-title":"Editorial: shifting gears in osteoarthritis research toward symptomatic osteoarthritis","volume":"68","author":"Zhang","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2019.10.001_bib3","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: cumulative meta-analysis","volume":"364","author":"J\u00fcni","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.joca.2019.10.001_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.joca.2019.10.001_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.joca.2019.10.001_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.joca.2019.10.001_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries","volume":"10","author":"McGettigan","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.joca.2019.10.001_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2018-213089","article-title":"Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis","volume":"77","author":"Dubreuil","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2019.10.001_bib9","article-title":"Diclofenac use and cardiovascular risks: series of nationwide cohort studies","volume":"362","author":"Schmidt","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2019.10.001_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 3","key":"10.1016\/j.joca.2019.10.001_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199600523-00007","article-title":"Pharmacology and clinical experience with tramadol in osteoarthritis","volume":"52","author":"Katz","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.joca.2019.10.001_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11926-009-0002-8","article-title":"The use of opioids in the treatment of osteoarthritis: when, why, and how?","volume":"11","author":"Goodwin","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.joca.2019.10.001_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MJT.0b013e31815b035b","article-title":"Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic\/persistent pain","volume":"15","author":"Barkin","year":"2008","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.joca.2019.10.001_bib14","doi-asserted-by":"crossref","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","article-title":"Tramadol: understanding the risk of serotonin syndrome and seizures","volume":"131","author":"Hassamal","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.joca.2019.10.001_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.joca.2019.10.001_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/acr.22360","article-title":"Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis","volume":"66","author":"Wright","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2019.10.001_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.2019.1347","article-title":"Association of tramadol with all-cause mortality among patients with osteoarthritis","volume":"321","author":"Zeng","year":"2019","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.joca.2019.10.001_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00210-014-1056-3","article-title":"Effects of opioids on human serotonin transporters","volume":"388","author":"Barann","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.joca.2019.10.001_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB summary: tramadol pathway","volume":"24","author":"Gong","year":"2014","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.joca.2019.10.001_bib20","doi-asserted-by":"crossref","first-page":"1382 e1","DOI":"10.1016\/j.amjmed.2018.04.025","article-title":"Tramadol: understanding the risk of serotonin syndrome and seizures","volume":"131","author":"Hassamal","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.joca.2019.10.001_bib21","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.joca.2019.10.001_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.14105","article-title":"Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in\u00a0vitro: link to clinical reports of serotonin syndrome","volume":"175","author":"Rickli","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joca.2019.10.001_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pds.2130","article-title":"Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism","volume":"20","author":"Biere-Rafi","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.joca.2019.10.001_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.joca.2019.10.001_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1510\/icvts.2010.243600","article-title":"Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial","volume":"11","author":"Wagner","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.joca.2019.10.001_bib26","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","article-title":"The comparative safety of opioids for nonmalignant pain in older adults","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joca.2019.10.001_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clinthera.2017.12.011","article-title":"Analgesic use and risk for acute coronary events in patients with osteoarthritis: a population-based, nested case-control study","volume":"40","author":"Pontes","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.joca.2019.10.001_bib28","first-page":"75","article-title":"A\u00a0language of health in action: read Codes, classifications and groupings","author":"Stuart-Buttle","year":"1996","journal-title":"Proc AMIA Annu Fall Symp"},{"key":"10.1016\/j.joca.2019.10.001_bib29","unstructured":"First Databank. Multilex drug data file."},{"key":"10.1016\/j.joca.2019.10.001_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.joca.2019.10.001_bib31","first-page":"318","article-title":"Which deprivation? A comparison of selected deprivation indexes","volume":"13","author":"Morris","year":"1991","journal-title":"J\u00a0Public Health Med"},{"key":"10.1016\/j.joca.2019.10.001_bib32","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"Garcia Rodriguez","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.joca.2019.10.001_bib33","article-title":"Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care","volume":"343","author":"Rodriguez","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2019.10.001_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.joca.2019.10.001_bib35","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by modeling marginal distributions","volume":"84","author":"Wei","year":"1989","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.joca.2019.10.001_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of Martingale based residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.joca.2019.10.001_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)17864-7","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2019.10.001_bib38","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.joca.2019.10.001_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.joca.2019.10.001_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.joca.2019.10.001_bib41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.6058","article-title":"Metrics for covariate balance in cohort studies of causal effects","volume":"33","author":"Franklin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.joca.2019.10.001_bib42","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/bcp.13660","article-title":"Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: a population-based cohort study","volume":"84","author":"Iwagami","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.joca.2019.10.001_bib43","first-page":"50","article-title":"Effect of droperidol and tramadol combination on the hemostasis in rabbits","volume":"65","author":"Bol'shakov","year":"2002","journal-title":"Eksp Klin Farmakol"},{"key":"10.1016\/j.joca.2019.10.001_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.rvsc.2012.09.005","article-title":"ADP-induced platelet aggregation after addition of tramadol in\u00a0vitro in fed and fasted horses plasma","volume":"94","author":"Casella","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.joca.2019.10.001_bib45","first-page":"C39","article-title":"Haemostatic risk factors for cardiovascular diseases","volume":"19","author":"Koenig","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.joca.2019.10.001_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.joca.2019.10.001_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/1440-1681.12213","article-title":"Effects of opioid (tramadol) treatment on testicular functions in adult male rats: the role of nitric oxide and oxidative stress","volume":"41","author":"Ahmed","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.joca.2019.10.001_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1091581817753607","article-title":"Evidence for the involvement of the dopaminergic system in seizure and oxidative damage induced by tramadol","volume":"37","author":"Bameri","year":"2018","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.joca.2019.10.001_bib49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","article-title":"Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress","volume":"87","author":"Kinugawa","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.joca.2019.10.001_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0735-1097(01)01709-0","article-title":"Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression","volume":"39","author":"Sia","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.joca.2019.10.001_bib51","doi-asserted-by":"crossref","DOI":"10.2337\/dc08-0237","article-title":"Cumulative effect of oxidative stress-related gene polymorphisms on myocardial infarction in type 2 diabetes","volume":"32","author":"Katakami","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.joca.2019.10.001_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamainternmed.2014.6512","article-title":"Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain","volume":"175","author":"Fournier","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.joca.2019.10.001_bib53","series-title":"Tramadol History and Statistics","author":"Patterson","year":"2017"},{"key":"10.1016\/j.joca.2019.10.001_bib54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keu403","article-title":"Drug utilization in patients with OA: a population-based study","volume":"54","author":"Wilson","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458419312257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458419312257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:51:56Z","timestamp":1761018716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458419312257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1063458419312257"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2019.10.001","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of tramadol with risk of myocardial infarction among patients with osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}